Company InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Equities
SE0008966295
Pharmaceuticals
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals for Immunological Diseases
100.0
%
| 0 | nan % | 98 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| - | - | 98 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Eva Arlander
PRN | Corporate Officer/Principal | 60 | 22-05-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 | |
Karin Bernadotte
BRD | Director/Board Member | 61 | 21-12-31 |
Marlene Forsell
BRD | Director/Board Member | 48 | 20-03-31 |
Director/Board Member | 56 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 532,687,650 | 332,794,895 ( 62.47 %) | 0 | 62.47 % |
Company contact information
InDex Pharmaceuticals Holding AB
Berzelius vaeg 13
171 65, Solna
+46 8 12 20 38 50
http://www.indexpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |